Skip to main content

Table 2 Patient and disease characteristics at varicella diagnosis

From: Economic burden of varicella in children 1–12 Years of age in Hungary, 2011–2015

 

Outpatients (N = 75)

Inpatients (N = 81)

Patient characteristics

Age, years, mean (SD)

4.4 (2.0)

3.7 (2.1)

Gender, n (%)

 Male

33 (44.0%)

45 (55.6%)

 Female

42 (56.0%)

36 (44.4%)

Area of residence, n (%)

 Urban

71 (94.7%)

53 (65.4%)

 Rural

4 (5.3%)

28 (34.6%)

BMI, kg/m2, mean (SD)

15.3 (2.0)

15.8 (2.6)

Calendar year of diagnosis, n (%)

 2011

2 (2.7%)

4 (4.9%)

 2012

13 (17.3%)

18 (22.2%)

 2013

17 (22.7%)

9 (11.1%)

 2014

43 (57.3%)

40 (49.4%)

 2015

0 (0.0%)

10 (12.3%)

Disease characteristics

Maximum number of skin lesions during rash, n (%)

 < 50

51 (68.0%)

2 (2.5%)

 50–249

16 (21.3%)

59 (72.8%)

 250–500

7 (9.3%)

20 (24.7%)

 > 500

1 (1.3%)

0 (0.0%)

Patients with at least one complication, n (%)

9 (12.0%)

75 (92.6%)

Number of complications, n (% among those experiencing complications)

 1 complication

7 (77.8%)

44 (58.7%)

 > 1 complication

2 (22.2%)

31 (41.3%)

Patients who were immunocompromiseda, n (%)

0 (0.0%)

4 (4.9%)

  1. BMI body mass index, SD standard deviation
  2. aPatients were considered immunocompromised if they had at least one of the following conditions: HIV/AIDS, congenital immunodeficiency, received system steroids, or had any other immunocompromised condition listed in their medical history